Overview
Endometrics develops non-invasive diagnostic tests for endometriosis and women's health conditions using menstrual blood as an organ-proximal liquid biopsy. The company integrates tissue-derived biomarker discovery, proprietary bioinformatics, and at-home sampling for scalable molecular diagnostics of gynecologic diseases. Endometrics won first prize in the NIH RADx Tech ACT ENDO Challenge for its clinically graded test collected at home.
Frequently asked questions
- What diagnostic tests does Endometrics offer?
- Endometrics offers a non-invasive diagnostic test for endometriosis using menstrual blood analysis, featuring proprietary biomarkers and at-home collection for clinical grading.
- What are Endometrics' key capabilities in women's health?
- The company specializes in molecular diagnostics for gynecologic diseases, combining biomarker discovery, bioinformatics, and scalable at-home sampling from menstrual blood.
- Has Endometrics received regulatory or innovation recognition?
- Endometrics won first prize in the NIH RADx Tech ACT ENDO Challenge, recognizing its progress in developing novel non-invasive endometriosis diagnostics.